Evidence map›Paper›PMID 29567217›Full record

ArticleJournal of food and drug analysis2018

Bioactive polyphenols in kinkéliba tea (Combretum micranthum) and their glucose-lowering activities.

Cara Welch, Jing Zhen, Emmanuel Bassène, Ilya Raskin, James Edward Simon, Qingli Wu

Open access · hybridAbstract read
In one paragraph

Article in Journal of food and drug analysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Ethanolic Extract of Kinkeliba (International journal of molecular sciences · 2025
    Article
  3. Review
  4. Article
  5. Kinkéliba (Molecules (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Antimicrobial Activity ofJournal of inflammation research · 2021
    Article
  13. Antityrosinase Activity ofMolecules (Basel, Switzerland) · 2020
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Cara WelchThe New Use Agriculture and Natural Plant Products Program, Department of Plant Biology, School of Environmental and Biological Sciences, Rutgers University, 59 Dudley Road, New Brunswick, NJ 08901, USA.
Jing ZhenThe New Use Agriculture and Natural Plant Products Program, Department of Plant Biology, School of Environmental and Biological Sciences, Rutgers University, 59 Dudley Road, New Brunswick, NJ 08901, USA.
Emmanuel BassèneDepartment of Pharmacognosy and Botany, Faculty of Medicine, Pharmacy and Odontology, UCAD, BP 5281 Dakar Fann, Senegal.
Ilya RaskinThe New Use Agriculture and Natural Plant Products Program, Department of Plant Biology, School of Environmental and Biological Sciences, Rutgers University, 59 Dudley Road, New Brunswick, NJ 08901, USA.
James Edward SimonThe New Use Agriculture and Natural Plant Products Program, Department of Plant Biology, School of Environmental and Biological Sciences, Rutgers University, 59 Dudley Road, New Brunswick, NJ 08901, USA.
Qingli WuThe New Use Agriculture and Natural Plant Products Program, Department of Plant Biology, School of Environmental and Biological Sciences, Rutgers University, 59 Dudley Road, New Brunswick, NJ 08901, USA.
Rutgers, The State University of New Jersey · USCheikh Anta Diop University · SN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herbal tea kinkéliba prepared from the leaves of Combretum micranthum has been widely consumed in West African countries for its flavor, nutritional and medicinal properties. Under bio-guided screening, the kinkéliba leaves were chemically investigated using various chromatographic and spectrometric methods that led to the identification of thirteen different flavonoid compounds. Further biological tests illustrated that the identified compounds may have synergistic effects to decrease the expression of phosphoenolpyruvate carboxykinase (PEPCK) mRNA and glucose production in an H4IIE hepatoma cell line, indicating its potential use for insulin-resistant diabetes treatment. Further in vivo study on C57BL/6J mice indicates that kinkéliba can lower plasma glucose levels in a dose-dependent manner without significant weight loss and toxicity. The ethyl acetate extract in rich of flavonoids could also increase the glucose tolerance (GT) after seven weeks' administrations. Both in vitro and in vivo experiments support a potential new application of kinkéliba leaves as an anti-diabetes agent.

Indexed as

AnimalsBlood GlucoseCombretumDiabetes MellitusHumansHypoglycemic AgentsMaleMice, Inbred C57BLMolecular StructurePhosphoenolpyruvate Carboxykinase (ATP)Plant ExtractsPlant LeavesPolyphenolsBlood GlucoseHypoglycemic AgentsPhosphoenolpyruvate Carboxykinase (ATP)Plant ExtractsPolyphenolsAnti-diabetesCombretum micranthumFlavonoidKinkéliba

Identifiers

PMID29567217
PMCPMC9322244
OpenAlexW2625730970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.